Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00130377 |
Recruitment Status : Unknown
Verified January 2018 by Amit N. Patel MD MS, Amit, Patel N, M.D..
Recruitment status was: Recruiting
First Posted : August 15, 2005
Last Update Posted : January 19, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cardiovascular System Diseases (& [Cardiac]) | Biological: cell therapy | Phase 2 Phase 3 |
The clinical cell registry includes data on thoracic and cardiovascular diseases including:
Acute myocardial infarction, Chronic Angina, Heart Failure, Wound Healing including Sternal, Peripheral Arterial Disease, Critical Limb Ischemia, Type 2 Diabetes, COPD, Asthma. Neurological disorders registry is available to specifics sites if requested. Our own biological data at the University of Utah including co-localized data with Society of Thoracic Surgeons also is a part of this program. Cell based therapies that are autologous and allogeneic are included in the registry
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 1000 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Biological Cell Therapy for the Treatment of Patients With Thoracic & Cardiovascular Disease |
Study Start Date : | August 2002 |
Estimated Primary Completion Date : | December 2020 |
Estimated Study Completion Date : | December 2020 |
Arm | Intervention/treatment |
---|---|
Experimental: cell therapy
Patient receiving active biologic
|
Biological: cell therapy
autologous or allogeneic cells |
Placebo Comparator: control
Patient receiving placebo or standard of care
|
Biological: cell therapy
autologous or allogeneic cells |
- Safety - MACE - Death, Readmission, Reintervention [ Time Frame: 1 year ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age >=18 years old
- Approved consent to be enrolled in trial/registry
Exclusion Criteria:
- Prior malignancy in the 5 years before treatment in this study (other than curatively treated carcinoma in-situ of the cervix or non-melanoma skin cancer)
- Inability or unwillingness to comply with the treatment protocol, follow-up, research tests, or give consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00130377
Contact: Amit N. Patel, MD, MS | amit.patel@hsc.utah.edu | ||
Contact: Amit N Patel, MD,MS | amit.patel@hsc.utah.edu |
United States, Utah | |
University of Utah | Recruiting |
Salt Lake City, Utah, United States, 84132 | |
Contact: Amit Patel, MD MS amit.patel@hsc.utah.edu | |
Contact: Kristin Kolsch kristin.kolsch@hsc.utah.edu | |
Principal Investigator: Amit Patel, MDMS |
Principal Investigator: | Amit N. Patel, MD, MS | University of Utah |
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Amit N. Patel MD MS, Amit Patel, Amit, Patel N, M.D. |
ClinicalTrials.gov Identifier: | NCT00130377 |
Other Study ID Numbers: |
0506137 |
First Posted: | August 15, 2005 Key Record Dates |
Last Update Posted: | January 19, 2018 |
Last Verified: | January 2018 |
Stem Cell Heart Lung Vascular cell therapy registry |
Cardiovascular Diseases |